402 related articles for article (PubMed ID: 9459343)
1. A new method for quantifying platelet deposition in flowing native blood in an ex vivo model of human thrombogenesis.
Bossavy JP; Sakariassen KS; Barret A; Boneu B; Cadroy Y
Thromb Haemost; 1998 Jan; 79(1):162-8. PubMed ID: 9459343
[TBL] [Abstract][Full Text] [Related]
2. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
Cadroy Y; Horbett TA; Hanson SR
J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosis.
Bossavy JP; Sakariassen KS; Rübsamen K; Thalamas C; Boneu B; Cadroy Y
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1348-53. PubMed ID: 10323789
[TBL] [Abstract][Full Text] [Related]
4. Collagen induced thrombus formation at the apex of eccentric stenoses--a time course study with non-anticoagulated human blood.
Barstad RM; Kierulf P; Sakariassen KS
Thromb Haemost; 1996 Apr; 75(4):685-92. PubMed ID: 8743200
[TBL] [Abstract][Full Text] [Related]
5. Upstream thrombus growth impairs downstream thrombogenesis in non-anticoagulated blood: effect of procoagulant artery subendothelium and non-procoagulant collagen.
Sakariassen KS; Weiss HJ; Baumgartner HR
Thromb Haemost; 1991 May; 65(5):596-600. PubMed ID: 1871722
[TBL] [Abstract][Full Text] [Related]
6. Nonfractionated heparin fails to inhibit arterial thrombosis in a human ex vivo thrombosis model.
Bossavy JP; Cadroy Y; Sakariassen K; Boneu B; Barret A
Ann Vasc Surg; 1999 Jul; 13(4):393-401. PubMed ID: 10398736
[TBL] [Abstract][Full Text] [Related]
7. HN-11500--a novel thromboxane A2 receptor antagonist with antithrombotic activity in humans at arterial blood flow conditions.
Roald HE; Barstad RM; Engen A; Kierulf P; Skjørten F; Sakariassen KS
Thromb Haemost; 1994 Jan; 71(1):103-9. PubMed ID: 8165627
[TBL] [Abstract][Full Text] [Related]
8. Clopidogrel--a platelet inhibitor which inhibits thrombogenesis in non-anticoagulated human blood independently of the blood flow conditions.
Roald HE; Barstad RM; Kierulf P; Skjørten F; Dickinson JP; Kieffer G; Sakariassen KS
Thromb Haemost; 1994 May; 71(5):655-62. PubMed ID: 8091395
[TBL] [Abstract][Full Text] [Related]
9. Relative contributions of collagen and tissue factor to thrombus formation on damaged vascular vessels: in-vitro studies with circulating blood.
Lopez-Vilchez I; Tonda R; Hernandez RM; Navalon F; Diaz-Ricart M; Galan AM; Escolar G
Coron Artery Dis; 2009 Sep; 20(6):392-9. PubMed ID: 19561489
[TBL] [Abstract][Full Text] [Related]
10. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
[TBL] [Abstract][Full Text] [Related]
11. Effects of the oral anticoagulant phenprocoumon on blood coagulation and thrombogenesis induced by rabbit aorta subendothelium exposed to flowing human blood: role of dose and shear rate.
Inauen W; Bombeli T; Baumgartner HR; Haeberli A; Straub PW
J Lab Clin Med; 1991 Sep; 118(3):280-8. PubMed ID: 1919300
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet-dependent thrombosis by low molecular weight heparin (CY222): comparison with standard heparin.
Cadroy Y; Harker LA; Hanson SR
J Lab Clin Med; 1989 Oct; 114(4):349-57. PubMed ID: 2551985
[TBL] [Abstract][Full Text] [Related]
13. Modulation of procoagulant activity of extracellular endothelial matrix by anti-tissue factor antibody and the synthetic peptide Arg-Gly-Asp-Val. Experiments with flowing non-anticoagulated human blood.
Salatti JA; Anton P; Nemerson Y; Sakariassen KS
Blood Coagul Fibrinolysis; 1993 Dec; 4(6):881-90. PubMed ID: 8148480
[TBL] [Abstract][Full Text] [Related]
14. Relationship between endothelial tissue factor and thrombogenesis under blood flow conditions.
Diquélou A; Dupouy D; Gaspin D; Constans J; Sié P; Boneu B; Sakariassen KS; Cadroy Y
Thromb Haemost; 1995 Aug; 74(2):778-83. PubMed ID: 8585021
[TBL] [Abstract][Full Text] [Related]
15. The effect of platelet PlA polymorphism on experimental thrombus formation in man depends on blood flow and thrombogenic substrate.
Cadroy Y; Sakariassen K; Grandjean H; Thalamas C; Boneu B; Sié P
Thromb Haemost; 2001 Jun; 85(6):1097-103. PubMed ID: 11434691
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of the anticoagulant and anti-thrombotic effects of unfractionated heparin and a low molecular weight heparin (Fraxiparine) in an experimental model of human venous thrombosis.
Diquélou A; Dupouy D; Cariou R; Sakariassen KS; Boneu B; Cadroy Y
Thromb Haemost; 1995 Nov; 74(5):1286-92. PubMed ID: 8607111
[TBL] [Abstract][Full Text] [Related]
17. Initial interactions of platelets and plasma proteins in flowing non-anticoagulated human blood with the artificial surfaces Dacron and PTFE.
Roald HE; Barstad RM; Bakken IJ; Roald B; Lyberg T; Sakariassen KS
Blood Coagul Fibrinolysis; 1994 Jun; 5(3):355-63. PubMed ID: 8075307
[TBL] [Abstract][Full Text] [Related]
18. Iohexol, platelet activation and thrombosis. II. Iohexol-induced platelet secretion does not affect collagen-induced or tissue-factor-induced thrombus formation in blood that is anticoagulated with heparin and aspirin.
Sakariassen KS; Buchmann M; Hamers MJ; Stormorken H
Acta Radiol; 1998 Jul; 39(4):355-61. PubMed ID: 9685818
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions.
Hamada M; Sugimoto M; Matsui H; Mizuno T; Shida Y; Doi M; Fukushima H; Nishio K; Yoshioka A; Shima M
Thromb Haemost; 2011 Feb; 105(2):313-20. PubMed ID: 21136018
[TBL] [Abstract][Full Text] [Related]
20. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
